Resultats de la cerca - Jun Kawashima

  • Mostrar 1 - 17 resultats de 17
Refinar resultats
  1. 1
    ASO Author Reflections: Composite Endpoint of Liver Surgery: Redefining Metrics for Clinical Trials

    ASO Author Reflections: Composite Endpoint of Liver Surgery: Redefining Metrics for Clinical Trials per Jun Kawashima, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  2. 2
    Impact of Disability on Postoperative Outcomes After Gastrointestinal Cancer Surgery

    Impact of Disability on Postoperative Outcomes After Gastrointestinal Cancer Surgery per Shahzaib Zindani, Mujtaba Khalil, Selamawit Woldesenbet, Zayed Rashid, Abdullah Altaf, Jun Kawashima, Austin Schenk, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis

    A phase 1/2, open-label study evaluating twice-daily administration of momelotinib in myelofibrosis per Vikas Gupta, Ruben A. Mesa, Michael W. Deininger, Candido E. Rivera, Shireen Sirhan, Carrie Baker Brachmann, Helen Collins, Jun Kawashima, Yan Xin, Srđan Verstovšek

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach

    Predictive model for very early recurrence of patients with perihilar cholangiocarcinoma: a machine learning approach per Jun Kawashima, Yutaka Endo, Zayed Rashid, Abdullah Altaf, Selamawit Woldesenbet, Diamantis I. Tsilimigras, Alfredo Guglielmi, Hugo P. Marques, Shishir K. Maithel, Bas Groot Koerkamp, Carlo Pulitanò, Federico Aucejo, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in the United States (US)

    Post-Marketing Use Outcomes of an Anti-CD19 Chimeric Antigen Receptor (CAR) T Cell Therapy, Axicabtagene Ciloleucel (Axi-Cel), for the Treatment of Large B Cell Lymphoma (LBCL) in... per Marcelo C. Pasquini, Frederick L. Locke, Alex F. Herrera, Tanya Siddiqi, Armin Ghobadi, Krishna V. Komanduri, Zhen‐Huan Hu, Hua Dong, Peiman Hematti, Sarah Nikiforow, Patricia Steinert, Anna G. Purdum, Mary M. Horowitz, Michelle Hooper, Jun Kawashima, Caron A. Jacobson

    Publicat 2019
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials

    Momelotinib long-term safety and survival in myelofibrosis: integrated analysis of phase 3 randomized controlled trials per Srđan Verstovšek, Ruben A. Mesa, Vikas Gupta, David Lavie, Viviane Dubruille, Nathalie Cambier, Uwe Platzbecker, Marek Hus, Blanca Xicoy, Stephen T. Oh, Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Aaron T. Gerds, Miklós Egyed, Jiřı́ Mayer, Tomasz Sacha, Jun Kawashima, Marc Morris, Mei Huang, Claire Harrison

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

    ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial per Stephen T. Oh, Moshe Talpaz, Aaron T. Gerds, Vikas Gupta, Srđan Verstovšek, Ruben A. Mesa, Carole B. Miller, Candido E. Rivera, Angela G. Fleischman, Swati Goel, Mark Heaney, Casey L. O’Connell, Murat O. Arcasoy, Yafeng Zhang, Jun Kawashima, Tomas Ganz, Mark Kowalski, Carrie Baker Brachmann

    Publicat 2020
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials

    Momelotinib in Myelofibrosis Patients With Thrombocytopenia: Post Hoc Analysis From Three Randomized Phase 3 Trials per Jean‐Jacques Kiladjian, Alessandro M. Vannucchi, Aaron T. Gerds, Vikas Gupta, Srđan Verstovšek, Miklós Egyed, Uwe Platzbecker, Jiřı́ Mayer, Sebastian Grosicki, Árpád Illés, T Woźny, Stephen T. Oh, Donal P. McLornan, Ilya Kirgner, Sung‐Soo Yoon, Claire Harrison, Barbara Klencke, Mei Huang, Jun Kawashima, Ruben A. Mesa

    Publicat 2023
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis

    Changes in bone marrow fibrosis during momelotinib or ruxolitinib therapy do not correlate with efficacy outcomes in patients with myelofibrosis per Stephen T. Oh, Srđan Verstovšek, Vikas Gupta, Uwe Platzbecker, Timothy Devos, Jean‐Jacques Kiladjian, Donal P. McLornan, Andrew C. Perkins, María Laura Fox, Mary Frances McMullin, Adam J. Mead, Miklós Egyed, Jiří Mayer, Tomasz Sacha, Jun Kawashima, Mei Huang, Bryan Strouse, Ruben A. Mesa

    Publicat 2024
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Impact of Anatomical Resection on Non-transplantable Recurrence Among Patients with Hepatocellular Carcinoma: An International Multicenter Inverse Probability of Treatment Weighting Analysis

    Impact of Anatomical Resection on Non-transplantable Recurrence Among Patients with Hepatocellular Carcinoma: An International Multicenter Inverse Probability of Treatment Weightin... per Jun Kawashima, Yutaka Endo, Mujtaba Khalil, Selamawit Woldesenbet, Miho Akabane, Andrea Ruzzenente, Francesca Ratti, Hugo P. Marques, Sara Oliveira, Jorge Balaia, François Cauchy, Vincent Lam, George A. Poultsides, Minoru Kitago, Irinel Popescu, Guillaume Martel, Ana Gleisner, Thomas J. Hugh, Luca Aldrighetti, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States

    Real-World Evidence of Axicabtagene Ciloleucel for the Treatment of Large B Cell Lymphoma in the United States per Caron A. Jacobson, Frederick L. Locke, Long Ma, Julius Asubonteng, Zhen‐Huan Hu, Tanya Siddiqi, Sairah Ahmed, Armin Ghobadi, David B. Miklos, Yi Lin, Miguel‐Angel Perales, Matthew A. Lunning, Megan M. Herr, Brian T. Hill, Siddhartha Ganguly, Hua Dong, Sarah Nikiforow, Michele Hooper, Jun Kawashima, Hairong Xu, Marcelo C. Pasquini

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma

    The Influence of Tumor Burden Score and Lymph Node Metastasis on the Survival Benefit of Adjuvant Chemotherapy in Intrahepatic Cholangiocarcinoma per Jun Kawashima, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil, Miho Akabane, François Cauchy, Feng Shen, Shishir K. Maithel, Irinel Popescu, Minoru Kitago, Matthew J. Weiss, Guillaume Martel, Carlo Pulitanò, Luca Aldrighetti, George A. Poultsides, Andrea Ruzzente, Todd W. Bauer, Ana Gleisner, Hugo P. Marques, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional Analysis

    Recurrence-Free Survival as a Surrogate for Overall Survival Among Patients with Intrahepatic Cholangiocarcinoma Following Upfront Surgery: An International Multi-institutional Ana... per Jun Kawashima, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil, Miho Akabane, François Cauchy, Feng Shen, Shishir K. Maithel, Irinel Popescu, Minoru Kitago, Matthew J. Weiss, Guillaume Martel, Carlo Pulitanò, Luca Aldrighetti, George A. Poultsides, Andrea Ruzzente, Todd W. Bauer, Ana Gleisner, Hugo P. Marques, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    International Validation and Refinement of Oncological Borderline Resectability Criteria for Hepatocellular Carcinoma Using Tumor Burden Score to Predict Survival

    International Validation and Refinement of Oncological Borderline Resectability Criteria for Hepatocellular Carcinoma Using Tumor Burden Score to Predict Survival per Miho Akabane, Jun Kawashima, Abdullah Altaf, Selamawit Woldesenbet, François Cauchy, Federico Aucejo, Irinel Popescu, Minoru Kitago, Guillaume Martel, Rebecca Marino, Luca Aldrighetti, George A. Poultsides, Yuki Imaoka, Andrea Ruzzenente, Itaru Endo, Ana Gleisner, Hugo P. Marques, Sara Oliveira, Jorge Balaia, Vincent Lam, Thomas J. Hugh, Nazim Bhimani, Feng Shen, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics

    Enhancing Recurrence-Free Survival Prediction in Hepatocellular Carcinoma: A Time-Updated Model Incorporating Tumor Burden and AFP Dynamics per Miho Akabane, Jun Kawashima, Abdullah Altaf, Selamawit Woldesenbet, François Cauchy, Federico Aucejo, Irinel Popescu, Minoru Kitago, Guillaume Martel, Francesca Ratti, Luca Aldrighetti, George A. Poultsides, Yuki Imaoka, Andrea Ruzzenente, Itaru Endo, Ana Gleisner, Hugo P. Marques, Sara Oliveira, Jorge Balaia, Vincent Lam, Thomas J. Hugh, Nazim Bhimani, Feng Shen, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size

    A Composite Endpoint of Liver Surgery (CELS): Development and Validation of a Clinically Relevant Endpoint Requiring a Smaller Sample Size per Jun Kawashima, Miho Akabane, Yutaka Endo, Selamawit Woldesenbet, Mujtaba Khalil, Kota Sahara, Andrea Ruzzenente, Luca Aldrighetti, Todd W. Bauer, Hugo P. Marques, Rita de Cássia Sobreira Lopes, Sara Oliveira, Guillaume Martel, Irinel Popescu, Matthew J. Weiss, Minoru Kitago, George A. Poultsides, Kazunari Sasaki, Shishir K. Maithel, Tom Hugh, Ana Gleisner, Federico Aucejo, Carlo Pulitanò, Feng Shen, François Cauchy, Bas Groot Koerkamp, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary Management

    Oncological Resectability Criteria for Intrahepatic Cholangiocarcinoma: A Preoperative Framework for Multidisciplinary Management per Jun Kawashima, Miho Akabane, Selamawit Woldesenbet, Diamantis I. Tsilimigras, Yutaka Endo, Kota Sahara, François Cauchy, Federico Aucejo, Hugo P. Marques, Rita de Cássia Sobreira Lopes, Andreia Rodriguea, Tom Hugh, Feng Shen, Shishir K. Maithel, Bas Groot Koerkamp, Irinel Popescu, Minoru Kitago, Matthew J. Weiss, Guillaume Martel, Carlo Pulitanò, Luca Aldrighetti, George A. Poultsides, Andrea Ruzzente, Todd W. Bauer, Ana Gleisner, Itaru Endo, Timothy M. Pawlik

    Publicat 2025
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: